Principal Investigator
Byron Lam
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231104
Clinical Trial Summary
A PHASE 1/2 STUDY TO ASSESS THE SAFETY AND EFFICACY OF OCU410ST FOR STARGARDT DISEASE
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other